Effects of cyclosporine A in hyperzincaemia and hypercalprotectinaemia

Acta Paediatrica, International Journal of Paediatrics

Volumn 95, Issue 7, 2006, Pages 857-860

  Sugiura, Tokio ^c   Goto, Kenji ^c   Ito, Kouichi ^c   Ban, Kyoko ^b   Okada, Shoji ^a   Moriyama, Akihiko ^a   Togari, Hajime ^c  

^a NAGOYA CITY UNIVERSITY   (Japan)

^b Yokkaichi City Hospital   (Japan)

^c NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

Calprotectin; Cyclosporine A; Hyperzincaemia and hypercalprotectinaemia; Interleukin 8; Pyoderma gangreosum

Indexed keywords

CALPROTECTIN; CYCLOSPORIN A; CYTOKINE; INTERLEUKIN 8; IRON; ZINC;

ANEMIA; ARTHRITIS; ARTICLE; BLOOD LEVEL; CASE REPORT; DRUG EFFICACY; FAILURE TO THRIVE; FEMALE; HEPATOSPLENOMEGALY; HUMAN; HYPERCALPROTECTINEMIA; HYPERZINCEMIA; METABOLIC DISORDER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PYODERMA GANGRENOSUM; RARE DISEASE; RECURRENT INFECTION; SCHOOL CHILD; SKIN INFLAMMATION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TREATMENT OUTCOME; ZINC BLOOD LEVEL;

CHILD; CYCLOSPORINE; CYTOKINES; FEMALE; HEPATOMEGALY; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATION; LEUKOCYTE L1 ANTIGEN COMPLEX; METABOLISM, INBORN ERRORS; METAL METABOLISM, INBORN ERRORS; PYODERMA; SPLENOMEGALY; ZINC;

EID: 33747626745     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1080/08035250500482255     Document Type: Article

References (18)

1. Sampson B, Fagerhol MK, Sunderkotter C, Golden BE, Richmond P, Klein N, et al. Hyperzincaemia and hypercalprotectinaemia: a new disorder of zinc metabolism. Lancet 2002;360:1742-5.
2. Hambidge KM, Norris DA, Githens JH, Ambruso D, Catalanotto FA. Hyperzincaemia in a patient with pyoderma gangrenosum. J Pediatr 1985;106:450-1.
3. Saito Y, Saito K, Hirano Y, Ikeya K, Suzuki H, Shishikura K, et al. Hyperzincaemia with systemic inflammation: a heritable disorder of calprotectin metabolism with rheumatic manifestations? J Pediatr 2002;140:267-9.
4. Sugiura T, Goto K, Ito K, Ueta A, Fujimoto S, Togari H. Chronic zinc toxicity in an infant who received zinc therapy for atopic dermatitis. Acta Paediatrica 2005;94:1333-5.
5. Elgart G, Stover P, Larson K, Sutter C, Scheibner S, Davis B, et al. Treatment of pyoderma gangrenosum with cyclosporine: results in seven patients. J Am Acad Dermatol 1991;24:83-6.
6. Matis WL, Ellis CN, Griffiths CE, Lazarus GS. Treatment of pyoderma gangrenosum with cyclosporine. Arch Dermatol 1992;128:1060-4.
7. Lyon CC, Smith AJ, Beck MH, Wong GA, Griffiths CE. Parastomal pyoderma gangrenosum: clinical features and management. J Am Acad Dermatol 2000;42:992-1002.
8. Vidal D, Puig L, Gilaberte M, Alomar A. Review of 26 cases of classical pyoderma gangrenosum: clinical and therapeutic features. J Dermatolog Treat 2004;15:146-52.
9. Sampson B, Kovar IZ, Rauscher A, Fairweather-Tait S, Beattie J, McArdle HJ, et al. A case of hyperzincaemia with functional zinc depletion: a new disorder? Pediatr Res 1997;42:219-25.
10. Steinbakk M, Naess-Andresen CF, Lingaas E, Dale I, Brandtzaeg P, Fagerhol MK. Antimicrobial actions of calcium binding leucocyte L1 protein, calprotectin. Lancet 1990;336:763-5.
11. Loomans HJ, Hahn BL, Li QQ, Phadnis SH, Sohnle PG. Histidine-based zinc-binding sequences and the antimicrobial activity of calprotectin. J Infect Dis 1998;177:812-4.
12. Boussac M, Garin J. Calcium-dependent secretion in human neutrophils: a proteomic approach. Electrophoresis 2000;21:665-72.
13. Voganatsi A, Panyutich A, Miyasaki KT, Murthy RK. Mechanism of extracellular release of human neutrophil calprotectin complex. J Leukoc Biol 2001;70:130-4.
14. Striz I, Trebichavsky I. Calprotectin - a pleiotropic molecule in acute and chronic inflammation. Physiol Res 2004;53:245-53.
15. Ryckman C, Vandal K, Rouleau P, Talbot M, Tessier PA. Proinflammatory activities of S100: proteins S100A8, S100A9, and S100A8/A9 induce neutrophil chemotaxis and adhesion. J Immunol 2003;170:3233-42.
16. Ahmad A, Bayley DL, He S, Stockley RA. Myeloid related protein-8/14 stimulates interleukin-8 production in airway epithelial cells. Am J Respir Cell Mol Biol 2003;29:523-30.
17. Bunikowski R, Gerhold K, Brautigam M, Hamelmann E, Renz H, Wahn U. Effect of low-dose cyclosporin a microemulsion on disease severity, interleukin-6, interleukin-8 and tumor necrosis factor alpha production in severe pediatric atopic dermatitis. Int Arch Allergy Immunol 2001;125:344-8.
18. Neuber K, Hilger RA, Konig W. Interleukin-3, interleukin-8, FMLP and C5a enhance the release of leukotrienes from neutrophils of patients with atopic dermatitis. Immunology 1991;73:83-7.